Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,517 | -726 | -2,672 | -2,061 | -1,459 |
| Depreciation Amortization | 176 | 63 | 11 | 111 | 5 |
| Accounts receivable | 0 | 57 | 64 | 150 | 194 |
| Other Working Capital | 548 | 296 | 740 | 509 | 177 |
| Other Operating Activity | 251 | 98 | 290 | 19 | -62 |
| Operating Cash Flow | $-542 | $-212 | $-1,566 | $-1,272 | $-1,146 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | -3 | N/A | N/A | N/A |
| Investing Cash Flow | $-46 | $-3 | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 120 | 120 | 1,549 | 1,288 | 1,095 |
| Common Stock Issued | 670 | 500 | N/A | N/A | N/A |
| Other Financing Activity | -242 | -118 | 0 | 0 | 0 |
| Financing Cash Flow | $548 | $502 | $1,549 | $1,288 | $1,095 |
| Beginning Cash Position | 57 | 57 | 74 | 74 | 74 |
| End Cash Position | 16 | 344 | 57 | 90 | 24 |
| Net Cash Flow | $-41 | $287 | $-17 | $16 | $-51 |
| Free Cash Flow | |||||
| Operating Cash Flow | -542 | -212 | -1,566 | -1,272 | -1,146 |
| Capital Expenditure | -46 | -3 | N/A | N/A | N/A |
| Free Cash Flow | -589 | -215 | -1,566 | -1,272 | -1,146 |